Summary
More than 7 years after the diagnosis and treatment of breast cancer (T1N1aM0), multiple nodular foci were observed in the liver of a 40-year-old woman at ultrasonographic examination. The lesions were confirmed by CT scan, but CT-guided liver biopsy revealed only non-specific alterations. At subsequent peritoneoscopic examination, bluish-brown foci were indeed visible on the liver surface, but guided liver biopsies again failed to corroborate the suspected metastases. Instead, histology showed mild portal fibrosis, moderate steatosis and siderosis of hepatocytes, as before. Only the intense red fluorescence of part of the biopsy material under Wood's light suggested the diagnosis of chronic hepatic porphyria or porphyria cutanea tarda, here presumably as a consequence of prolonged alcohol consumption. Subsequent porphyrin studies in urine, faeces and plasma yielded the typical constellation of latent porphyria cutanea tarda (chronic hepatic porphyria type C). The activity of erythrocyte uroporphyrinogen decarboxylase was normal, which argued against a genetic predisposition. After 1 year of strict alcohol abstinence and low-dose chloroquine treatment the “nodular foci” in the liver were no longer visible on ultrasonogram and CT scan; only proton-weighted NMR imaging (SE 1500/30) still showed ill-defined areas of higher signal intensity. The renal excretion of porphyrins had decreased considerably. The levels are now consistent with the diagnosis of subclinical chronic hepatic porphyria type A. Modern non-invasive imaging techniques are tremendously useful, but they have their pitfalls. Focal liver lesions may present serious diagnostic problems, especially when they are found in a patient with a history of carcinoma at an extrahepatic primary site. A rare example is described.
Similar content being viewed by others
Abbreviations
- gamma-GT:
-
gamma glutamyl transpeptidase
- CEA:
-
carcinoembryonic antigen
- CA-15-3:
-
breast cancer associated antigen
- TPA:
-
tissue polypeptide antigen
- CHP:
-
chronic hepatic porphyria
- PCT:
-
porphyria cutanea tarda
- delta-ALA:
-
delta-amino-laevulinic acid
- CT:
-
computerised axial tomography
- NMR:
-
nuclear magnetic resonance
- T1, T2:
-
relaxation time
- TE:
-
echo time
- TR:
-
repetition time
- SE:
-
spin echo
References
Beyer D, Mödder U, Friedmann G (1984) Differentialdiagnose nodulärer Leberveränderungen bei seltenen Leberparenchymerkrankungen. — In: Lutz H, Reichel L (Hrsg) Ultraschall-Diagnostik 83. 7. Gemeinsame Tagung der deutschsprachigen Gesellschaften für Ultraschalldiagnostik. Thieme, Stuttgart New York, S 341–343
Dandurand M, Guillot B, Guilhou JJ (1986) Porphyrie cutanée tardive et néoplasies. A propos de deux observations. Ann Dermatol Vénérol 113:679–683
Denk R, Holzmann H (1969) Der dermatologische Fall: XLI. Paraneoplastische Porphyria cutanea tarda. Med Welt 20:1446–1447
Doss M (1971) Suggested pathobiochemical development of chronic hepatic porphyrias. Klin Wochenschr 49:941–942
Doss M (1981) Das porphyrinfluoreszierende Ei für den Hepatologen. Dtsch Med Wochenschr 106:911–914
Doss M (1982) Hepatic porphyrias. Pathobiochemical, diagnostic, and therapeutic implications. — In: Popper H, Schaffner F (eds) Progress in Liver Diseases, Vol. VII. Grune and Stratton, New York, pp 573–597
Doss M (1985) Alcohol and porphyrin metabolism. — In: Seitz HK, Kommerell B (eds) Alcohol Related Diseases in Gastroenterology. Springer, Berlin Heidelberg, pp 232–252
Doss M (1987) Porphyrinurias and occupational disease. Ann NY Acad Sci 514:204–218
Doss M, Meinhof W, Malchow H, Sodomann CP, Dölle W (1970) Charakteristische Konstellation der Urinporphyrine als biochemischer Index der Porphyria cutanea tarda. Klin Wochenschr 48:1132–1134
Fakan F, Chlumská A (1987) Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test. Virchows Arch A 411:365–368
Friedmann G, Beyer D (1984) Sonographie des hepatobiliären Systems. Dtsch Ärzteblatt 81:423–430
Goerz G, Strohmeyer G (1983) Porphyria cutanea tarda (PCT). Internist 24:543–549
Grossmann ME, Bickers DR (1979) Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med 67:227–280
Grouls V, Hey A (1987) Porphyria cutanea tarda: Pathognomonische Einschlüsse im Zytoplasma von Hepatozyten. Dtsch Med Wochenschr 112:157 (letter)
Henning H, Vogel HM, Doss M, Lüders CJ (1976) Chronische hepatische Porphyrie: Biochemische und histologische Befunde. Diagnostik 9:275–278
Henning H (1988) Laparoskopie — Relevante Indikationen. Verh Dtsch Ges Inn Med 94:626–628
Henning H (1988) Personal communication
Kamby C, Dirksen H, Vejborg I, Daugaard S, Guldhammer B, Rossing N, Mouridsen HT (1987) Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer 59:1524–1529
Kushner JP (1982) The enzymatic defect in porphyria cutanea tarda. New Engl J Med 306:799–800
Riedel H, Justus J, Köstler E, Pätzold K, Kemmer Ch (1984) Zur Morphologie des Leberschadens bei der chronischen hepatischen Porphyrie unter besonderer Berücksichtigung des Therapieeffektes. Pathologe 5:216–225
Sixel-Dietrich F, Doss M (1985) Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. Arch Dermatol Res 278:13–16
Vogel HM (1986) Sonographische Untersuchungen bei Leberkrankheiten. — In: Henning H (ed.) „Fortschritte der Leberdiagnostik in Klinik und Praxis“, 34. Ärztliches Seminar in Föhrenkamp, Mölln, Dezernat für Presse- und Öffentlichkeitsarbeit der BfA, Berlin, pp 36–47
Vorherr H (1981) Pathobiology of breast cancer: Hypothesis of biological predetermination and long-term survival. Klin Wochenschr 59:819–829
Wernecke K, Peters PE (1985) Sonographische und computertomographische Diagnostik von Lebermetastasen. Eine Übersicht. Radiologe 25:141–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lelbach, W.K., Müller, T.R., Kersjes, W. et al. Multiple nodular foci in the liver associated with chronic hepatic porphyria after previous treatment of breast cancer. Klin Wochenschr 67, 592–597 (1989). https://doi.org/10.1007/BF01721687
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01721687